Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 17 publications
Five Years of Ublituximab in Multiple Sclerosis: ULTIMATE I and II Open-Label Extension Study.
Journal: JAMA neurology
Published: February 16, 2026
Evaluation of Documented Infections by Provider Specialty in Patients with Multiple Sclerosis Receiving Disease-Modifying Therapies: A Claims Database Analysis.
Journal: Advances in therapy
Published: December 23, 2025
Disease outcomes with ublituximab in treatment-naïve participants: subpopulation analyses of the phase 3 ULTIMATE I and II studies in participants with relapsing multiple sclerosis.
Journal: Frontiers in immunology
Published: December 19, 2025
Efficacy of Ublituximab in People with Highly Active Relapsing Multiple Sclerosis.
Journal: Neurology and therapy
Published: December 16, 2025
The TRaditional versus Early Aggressive Therapy for Multiple Sclerosis (TREAT-MS) trial: design and baseline characteristics of participants.
Journal: Contemporary clinical trials
Published: May 12, 2025
Aquaporin-4 Immunoglobulin G-seropositive Neuromyelitis Optica Spectrum Disorder MRI Characteristics: Data Analysis from the International Real-World PAMRINO Study Cohort.
Journal: Radiology
Published: November 12, 2024
Improvements in no evidence of disease activity with ublituximab vs. teriflunomide in the ULTIMATE phase 3 studies in relapsing multiple sclerosis.
Journal: Frontiers in neurology
Published: July 30, 2024
High-dose vitamin D3 supplementation in relapsing-remitting multiple sclerosis: a randomised clinical trial.
Journal: EClinicalMedicine
Published: November 28, 2022
Ublituximab versus Teriflunomide in Relapsing Multiple Sclerosis.
Journal: The New England journal of medicine
Published: August 24, 2022
Quality of life in individuals newly diagnosed with multiple sclerosis or clinically isolated syndrome.
Journal: Journal of neurology
Published: March 09, 2021
Exercise training and cognition in multiple sclerosis: The GET Smart trial protocol.
Journal: Contemporary clinical trials
Published: December 11, 2020
Iron-Insensitive Quantitative Assessment of Subcortical Gray Matter Demyelination in Multiple Sclerosis Using the Macromolecular Proton Fraction.
Journal: AJNR. American journal of neuroradiology
Published: September 29, 2017
Last Updated: 09/26/2026